Accessibility Menu
Icon Public Stock Quote

Icon Public (NASDAQ: ICLR)

$192.60
(-0.3%)
-0.66
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$192.6
Daily Change
(-0.3%) $0.66
Day's Range
$189 - $197.92
Previous Close
$192.6
Open
$194.74
Beta
1.05
Volume
1,844,845
Average Volume
1,144,042
Market Cap
15B
Market Cap / Employee
$192.60M
52wk Range
$125.1 - $242.72
Revenue
-
Gross Margin
0.24%
Dividend Yield
N/A
EPS
$9.73
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Icon Public Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ICLR-32.06%-0.9%-0.18%+2,939%
S&P+14.5%+93.32%+14.09%+504%

Icon Public Company Info

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$2.02B-4.8%
Gross Profit$463.88M-2.7%
Gross Margin22.99%0.5%
Market Cap$11.75B-54.7%
Market Cap / Employee$0.29M-53.3%
Employees39.9K0.0%
Net Income$182.97M24.5%
EBITDA$366.19M-16.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$390.40M-22.9%
Accounts Receivable$2.61B-6.7%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$3.52B-1.0%
Short Term Debt$29.76M0.0%

Ratios

Q2 2025YOY Change
Return On Assets4.73%0.5%
Return On Invested Capital6.08%-3.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$127.55M-29.3%
Operating Free Cash Flow$162.19M-25.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings31.9921.9919.0414.95-59.03%
Price to Book2.431.771.481.22-55.73%
Price to Sales2.892.081.731.43-54.40%
Price to Tangible Book Value-8.13-5.94-4.58-3.77-51.50%
Price to Free Cash Flow TTM19.5215.6313.5811.69-47.54%
Enterprise Value to EBITDA67.6939.2446.5140.22-39.42%
Free Cash Flow Yield5.1%6.4%7.4%8.6%90.64%
Return on Equity8.0%8.4%8.0%8.3%6.77%
Total Debt$3.58B$3.60B$3.56B$3.55B-1.02%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.